GENERIUM is a full-cycle research and production company and a leader in the orphan segment of the Russian pharmaceutical market.

The company has its own research and development (R&D) park, which is capable of developing any biotechnological drug, from the creation of a molecule to the initiation of industrial production.

The company production facility is meticulously organized in strict accordance with international GMP standards and produces a unique range of biotechnological drugs and biomedical cellular products.

Read more: www.generium.ru

Russia, 601125 Vladimir region, Petushinsky district, Volginsky village, 273 Zavodskaya St.
+7 (4922) 37-93-17
Russia, 123112 Moscow, 10 Testovskaya St, entrance 2
+7 (495) 988-47-94

e-mail: generium@generium.ru

ABV-Test LLC is a developer and manufacturer of a unique set of reagents for the quantitative determination of TREC and KREC DNA using PCR-RV in nucleic acid samples obtained from whole blood or dried human blood spots. This test is utilized to diagnose pathological conditions caused by T and B cell deficiencies, without grading based on demographic or population factors. In 2022, a combined reagent kit, “TK-SMA,” was developed and registered for the diagnosis of immunodeficiency conditions and spinal muscular atrophy. It is now widely used as part of expanded screening.

The Company products are:

• IMMUNO-BIT - Reagent kit for the quantitative determination of TREC and KREC DNA, No. P3H 2021/15873, dated November 29, 2021.
• TK-SMA - Reagent kit for the isolation and quantification of TREC and KREC DNA, as well as the qualitative detection of the homozygous deletion of exon 7 of the SMN1 gene, № P3H 2022/18080, dated August 10, 2023.

Russia, 121205 Moscow, Skolkovo Innovation Center, 7 Nobel Street, floor 2 Part of Bld. 51

Chiesi is an international biopharmaceutical group that focuses on scientific research and specializes in the development and marketing of innovative therapeutic solutions in the fields of pulmonology, rare diseases, and specialized therapies.

Chiesi Global Rare Diseases is a specialized unit within the Chiesi Group, focused on the development and marketing of innovative medicines and therapeutic solutions for patients with rare diseases. Thanks to the family-oriented nature of the business, the Chiesi Group strives to create a world where cures for all diseases are attainable and serves as a positive force for society and the planet.

The goal of Chiesi Global Rare Disease is to ensure equitable access to treatment for all, allowing as many individuals as possible to experience the fullness of life. Our experts collaborate worldwide with all stakeholders involved in rare diseases, advocating for the interests of those whose voices are often overlooked in the healthcare system.

For more information, please visit www.chiesirarediseases.com

Biomedica is a pharmaceutical company dedicated to transforming lives by providing access to innovative treatments to patients with rare diseases in underserved and emerging markets. We believe that access to essential medicines is a fundamental human right, and it our mission to ensure healthcare equity globally, regardless of geography or economic status.

We employ a team of highly skilled professionals, committed to ensuring that modern therapeutics reach individuals in emerging markets, making a real difference in their quality of life. Biomedica is patient-oriented, quality-focused, and operates ethically in accordance with global and regional regulations.

Bulgaria, 1404 Sofia, 109 Bulgaria Blvd, Biomedica South Europe and Black Sea Vertigo Business Tower,

contactoffice@biomedica.bio

PTC is a global biopharmaceutical company dedicated to discovering, developing, and bringing clinically relevant medicines to market for patients with rare diseases.

Established 20 years ago, PTC Therapeutics has successfully introduced several rare disease drugs to the international market and is globally recognized for its contributions. The company consistently invests in the development of new drugs and research in the field of pathogenesis, including gene therapy, for rare diseases. This commitment aligns with its mission to ensure access to the best treatments for patients in need.

Kazakhstan, 050040 Almaty, Bostandyk district, 26/29 Timiryazeva St., 7th floor, office 701
e-mail: info@ptcbio.com
www.ptcbio.com

Swix BioPharma is a pharmaceutical company dedicated to representing subsidiaries or individual business units of multinational biopharmaceutical corporations in regions or therapeutic areas where they do not currently operate. The company employs experienced professionals whose mission is to deliver modern medicines to the people of Central and Eastern Europe. We pride ourselves on being a service-oriented, quality-driven, and ethical organization. Swixx BioPharma commenced operations in December 2014 and is registered in Baar, Switzerland.

Russia, 105064 Moscow, 9 Zemlyanoi val St.
+7 (495) 229-06-61
e-mail: russia.info@swixxbiopharma.com

FERON LLC is a Russian full-cycle pharmaceutical company specializing in the production and promotion of antiviral immunomodulatory drugs, including Viferon®️ (available in rectal suppositories, ointment, and gel forms).
Viferon®️ is widely utilized in pediatrics, neonatology, gynecology, dermatology, urology, therapy, and infectology. A distinctive feature of Viferon® is suitability for therapy in children from the first days of life and in pregnant women.

For 25 years, the company has accumulated extensive experience in the use of Viferon®️ for the treatment of a wide range of diseases, including ARVI, influenza, herpesvirus infections, urogenital infections, viral hepatitis, and others. The drug production process is organized in accordance with the highest international standards. FERON LLC became one of the first Russian manufacturers to receive certification from the Ministry of Industry and Trade of the Russian Federation, confirming that its production complies with international quality standards (GMP2).

Russia, 125167 Moscow, 37 Leningradsky Avenue
+7 (495) 646-12-19
viferon.su

AstraZeneca is an international biopharmaceutical company focused on the research, development and market launch of prescription drugs primarily in such therapeutic areas as oncology, cardiology, nephrology and metabolism, respiratory and autoimmune, as well as rare diseases. AstraZeneca, based in Cambridge, UK, is represented in more than 100 countries around the world, and its innovative drugs are used by millions of patients worldwide.

123112, Moscow, 1st Krasnogvardeisky passage, 21, building 1., 30th floor
Phone: +7 (495) 799-56-99
Website: www.astrazeneca.ru

BGI is the world leading provider of genomic sequencing and proteomics services.

We empower scientists and researchers to achieve their full potential by offering fully integrated genome sequencing, proteomic services, and high-quality solutions for a variety of applications.

We are dedicated to promoting and accelerating scientific innovation, improving the prevention and management of genetic diseases, and equipping healthcare providers with advanced diagnostic tools. BGI is devoted to making significant contributions to precision medicine and diagnostics.

Backed by advanced sequencing and bioinformatics technologies, BGI offers its customers expert and cost-effective solutions for clinical molecular diagnostics and high-throughput sequencing (NGS) research services. These solutions have facilitated groundbreaking research that was unimaginable just a few years ago. Our services extend to over 100 countries and regions, encompassing more than 2,300 medical centers.

BGI Group was established in 1999 as a research organization dedicated to supporting the Human Genome Project. Over the years, our research has significantly contributed to the field of genomics, as demonstrated by numerous peer-reviewed publications in esteemed scientific journals.

In Tashkent, BGI is the founder of the molecular genetics laboratory “Genscreen”.

We are committed to making a positive impact on people lives and are unafraid to make bold decisions that can lead to significant breakthroughs. BGI believes that our business success will contribute to a better world for everyone. We believe in a brighter future.

Republic of Uzbekistan, 100031 Tashkent, Yakkasaray district, 21 Rakatboshi St.
Russia, 115093 Moscow, 1 Partiyny alley, building 57-3
+99894 955 5884 (Uzbekistan)
info@bgi.com

www.bgi.com/global

ROSSА is the largest scientific and production complex dedicated to the development of biotechnological products in the Republic of Uzbekistan. We hold a leading position in the production of in-vitro diagnostics (IVD) in our country, combining the research expertise of scientists and technologists, along with modern biotechnological manufacturing processes. Our preclinical and clinical trials adhere to international standards, as evidenced by ISO 90001-2015 and ISO 13485-2017 certificates.

Our goal is to ensure the biosafety of the country in the fields of healthcare and the veterinary food industry.

Republic of Uzbekistan, Tashkent Region, Nurafshon, 93 Rohat St.

www.rossa.uz

Petrovax is a Russian biotechnology company with 25 years of successful experience in the pharmaceutical market. Its product portfolio includes original medicines, vaccines, biotechnological products, and branded generics.

Petrovax holds patents for molecules and technologies both in Russia and internationally. The company R&D center for preclinical research enables it to conduct a complete cycle of drug development.

The company pharmaceutical production complex, situated in the Moscow region, operates in compliance with EAEU and EU GMP standards. The facility synthesizes pharmaceutical substances and manufactures both sterile and non-sterile medications in various dosage forms. Its production capacity is 160 million doses per year.
Petrovax is one of Russia largest exporters of original medicines and vaccines. The products are supplied to countries in the EAEU and the EU, including Slovakia.

Petrovax is involved in over 10 international projects in collaboration with leading pharmaceutical companies, including Pfizer, Abbott, ISU ABXIS, Adimmune, and Hengrui.

The company is conducting the first technology transfer in Russia, which includes the synthesis of a cell line-based substance, an orphan drug (agalsidase beta) for the treatment of Fabry disease, in collaboration with ISU Abxis and Gamaleya NICEM.

A project is currently underway to introduce the original oncological drug camrelizumab to the Russian market in partnership with Jiangsu Hengrui, with plans for subsequent localization in Russia.
The development strategy aims to provide patients with essential vaccines and medications for the treatment of oncological and orphan diseases.

The company employs over 700 individuals.
Petrovax mission is to provide innovative medicines that enhance health and improve quality of life.

Russia, Moscow, 12 Presnenskaya embankement, Federation Tower East
+7 (495) 730-75-45

info@petrovax.ru

BIOCAD is one of the largest biotechnology innovation companies in Russia, integrating world-class research and development (R&D) centers with modern pharmaceutical and biotech production facilities, as well as preclinical and clinical trials that adhere to international standards.

BIOCAD is a full-cycle drug development company that encompasses everything from molecule discovery to mass production and marketing support. The drugs are designed to treat oncological, autoimmune, and other socially significant diseases. The company product portfolio includes 64 drugs, of which 11 are original compounds and 23 are biologics. Currently, approximately 40 products are in various stages of development.

The company employs over 3,000 individuals, one-third of whom are scientists and researchers. It has representative offices in Brazil, Vietnam, India, and the UAE. A joint venture between BIOCAD and Shanghai Pharmaceuticals Holding, known as SPH-Biocad (HK) Ltd., operates in China.

www.biocad.ru
e-mail: biocad@biocad.ru

+7 (812) 380-49-33 (Ext. 650 and 6350)

Promix is a young, rapidly growing Russian company that specializes in the development and manufacturing of specialized products for therapeutic and preventive dietary nutrition, including for patients with ultra-rare diseases. We create innovative formulations for specialized nutrition products and enhance technologies for the targeted delivery of micronutrients in the pharmaceutical industry.

With our expertise in pharmaceutical manufacturing, we apply its culture and quality control methodologies to specialty nutrition product technologies. We believe that every product we manufacture and sell must adhere to the highest government standards.

For every product we manufacture, we conduct clinical trials in accordance with Good Clinical Practice (GCP) standards. We believe that evidence-based medicine enables us to contribute to the treatment of patients with orphan diseases.

Russia, 196191 St. Petersburg, 168 Leninsky Avenue, Lit. A, Office #20-21
+7 (911) 700-16-09
e-mail promix@promixspb.com

promixspb.ru

Infaprim is a Russian company that specializes in the production of baby food, as well as specialized and therapeutic nutrition.

We ensure that those for whom it is particularly important receive high-quality, healthy products.

• Pregnant and lactating women: NutriMa Femilac and NutriMa Lactamil
• Newborns and infants, both healthy and those with special nutritional needs: Nutrilak infant formula and milk, Pooh cereal, Nutrilak Procereals, and Nutrigen.
• Patients in hospitals requiring specialized care, including tube feeding: Nutrien.
• Nutrition for athletes: Nutrisport Reforce

When developing our products, we take market trends and consumer needs into account. To create the best possible offerings, we collaborate with leading experts in pediatrics and nutritional science, utilizing scientific research data. The effectiveness of our products is clinically proven.

Uzbekistan, Tashkent, Mirzo-Ulugbek district, 7 Salar Buyi St.
+998901290666
e-mail: info@infaprim.com
www.infaprim.com

www.nutrilak.com

Pribori Oy – is an exclusive distributor of Wallac Oy/Revvity. Equipment and reagents for endocrinology, cardiology, oncology, prenatal and neonatal diagnostics, microbiology, genetics and molecular biology.

Pribori Oy company is one of the largest suppliers of modern high-tech equipment in Central Asia and in other CIS countries. For many years the Company is an exclusive distributor of the equipment for genetic screening, laboratory assays, clinical diagnostics and radiation control.

During existence of the Company projects on equipment of the leading branch enterprises were successfully realized, among which: hospitals and laboratories, pharmaceutical enterprises, nuclear power plants and research institutes.

Pribori Oy is a team of highly qualified specialists who are able to implement new advanced technologies.

Finland, 02150 Espoo, Keilaranta 1
e-mail: info@pribori.com
www.pribori.com

ALPHAMEDICA is an experienced medical technology company that is an authorized representative of Thermo Fisher Scientific USA. The company provides a wide range of laboratory solutions encompassing genetics, transplantation, microbiology, and general laboratory equipment. In addition to Thermo Fisher products, ALPHAMEDICA portfolio includes equipment from manufacturers such as Sakura Japan, Nikon Japan, Becton Dickinson USA, establishing it as a reliable partner for laboratories and medical institutions seeking advanced instruments for research and diagnostics.

Uzbekistan, 100000 Tashkent, 50 Sairam 7-tor St., Mirzo-Ulugbek branch of JSCB “Kapitalbank”.
+998 95 195 99 98

Over 20 years of experience in importing and distributing laboratory equipment.

We offer tailored solutions by integrating innovative technologies and services from the world leading brands, including Thermo Fisher Scientific, Applied Biosystems, Invitrogen, and Fisher Scientific.

We serve various sectors, including science, agriculture, and medicine, in Uzbekistan and Tajikistan by providing turnkey solutions for our customers.

“Hayot” means ‘Life’ in Uzbek. Our goal is to promote innovative solutions across various fields, assisting our clients in discovering ways to improve life and create a better future.


Uzbekistan, 100000 Tashkent, Shaykhantokhursky district, 1A Furkat St.
Phone/Fax: (+998 90) 187-21-24
e-mail: info@hayot-tech.uz
www.hayot-tech.com

Founded in Istanbul in 2013, Gen Era stands out as the leading provider of diagnostic and life sciences products and services in Turkey.​

With over 10 years of experience, we are dedicated to advancing molecular diagnostics and life sciences, providing customized solutions for scientists, clinicians, laboratories and patients.​

With the right focus, Gen Era has created revolutionary changes in laboratory services in Turkey, enabling previously inaccessible tests to be performed and significantly increasing the capabilities of local laboratories. Gen Era is a leader in the industry with a wide product portfolio and dedicated , well educated team.
​
We are distributor of 10X Genomics, Amoy Dx, ArcherDx now IDT, BioRad, Hamilton Robotics, Illumina, Proteintech, Revvity, Paragon Genomics, SeraCare, SOPHiA GENETiCS and Takara.

Today, we provide services in Turkey, Turkish Republic of Northern Cyprus, Azerbaijan, Armenia, Kazakhstan, Kyrgyzstan, Uzbekistan, Tajikistan and Turkmenistan.

Turkey, 34746 Ataşehir/İstanbul, Palladium Tower İş Merkezi Barbaros Mah Kardelen Sok. No:2 Kat:14 İç Kapı No:46
+90 216 455 58 22
e-mail: info@gen-era.com.tr

Albatros Healthcare
Uzbekistan, Tashkent, 17 Khalkobad St.
+998 78 152 02 22
e-mail: info@ahc.uz

Helicon is one of the leading Russian suppliers of products for scientific, diagnostic and production laboratories. The company provides a range of services from design and delivery to equipment start-up, on-site personnel training and qualified service.

The product catalog includes over 20,000 products from more than 60 manufacturers.

Russia, 121374 Moscow, 88 Kutuzovsky Avenue
+7 (800) 770-71-21
e-mail: mail@helicon.ru
www.helicon.ru
Telegram: https://t.me/HeliconCompany

VK: https://vk.com/helicon.company

Established in 2007, Sesana represents Genomed Holding, which encompasses a distribution division, the production of scientific and medical products, as well as service and clinical laboratories.

With extensive expertise in molecular biology, sequencing, microarray analysis, and other related fields, we do not merely sell equipment. Sesana provides professional support, guidance on equipment and reagent selection, as well as the implementation and maintenance of methods and technologies. When you reach out to us, you will always receive advice from experts who possess hands-on experience with the equipment we offer.

Representing a diverse array of leading brands in the life sciences, we offer equipment and reagents for the complete cycle of scientific research, from DNA extraction to bioinformatics analysis.

You are always welcome to borrow our demonstration equipment and try it out for yourself. Our laboratory doors are always open to you. You can receive training or work with our equipment at any time that is convenient for you.

Russia, 107014 Moscow, 8 Korolenko St.
+7 (705) 764-00-31
e-mail: ib@sesana.kz

https://sesana.ru/

Created by scientists for scientists, NEB prioritizes the advancement of science, stewardship of the environment, and giving back to the world around us in everything we do. Since our establishment in 1974, we have remained committed to developing high quality, innovative products that not only empower your research but also our own. Our profits have always funded an extensive research program, which we believe is critical for staying connected to our customers and helping to drive scientific breakthroughs. From our founding principles to our unique corporate culture, NEB’s philosophy can be distilled down to three core values: passion, humility and being genuine.

NEB offers the largest selection of recombinant and native enzymes for genomic research. While restriction enzymes remain part of our core product portfolio, our ever-expanding catalog also includes products related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, we are also focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development and nucleic acid vaccines. As we reflect on the last 50 years and look toward the future, we are excited to support your research and help you address the complex challenges facing the world today. We hope that by working together we can shape the science of tomorrow.

Germany, D-65926 Frankfurt am Main, Bruningstrasse 50; Geb. B852 (Industriepark Hoechst)
+49-69-305-23149

e-mail: info.de@neb.com

PanEco is a Russian manufacturer specializing in nutrient media for mammalian and human cell cultures. With over 25 years of experience, we provide laboratory and culture plastics, reagents, equipment, and other consumables for laboratories, pharmaceutical production, and research institutes.
Our production facility is situated in the Moscow region and is established on our own premises. This strategic location enables us to broaden our range of manufactured goods and to develop new innovative products.

Currently, we are the leading manufacturer in the Russian Federation in several sectors, namely:

• A line of media for cytogenetic diagnostics of human chromosomal pathology (such as phytohemagglutinin, Lymphokar, Amniokar, etc.). The products possess Registration Certificates (RU) from Roszdravnadzor.
• Nutrient media for in vitro fertilization (more than 10 items). The products possess Registration Certificates (RU) from Roszdravnadzor.
• Since 2024, the "Lymphogen" nutrient medium designed for the early diagnosis of tuberculosis is produced. The product possesses a Registration Certificate (RU) from Roszdravnadzor.

Our Strengths and Advantages:

• Own production of nutrient media, component by component
• Classical recipes and production according to the customer specifications
• Effective management of raw material inputs and stringent quality control of finished products
• Availability of Registration Certificates for Our Products
• Worldwide delivery of products in compliance with the T-regime
• Prompt feedback.

Russia, 115477 Moscow, 58 Kantemirovskaya St.

e-mail: info@paneco.ru

www.paneco-ltd.ru
www.paneco.ru

8 800 550 72 31

Aston Health offers cutting-edge technology and reliable data to address business challenges faced by pharmaceutical manufacturers, distributors, pharmacy chains, medical and patient communities, government agencies, and professional associations within the healthcare sector.

Since 1999, the company has focused on studying, systematizing, and developing this market. We possess a strong understanding of its mechanisms, evaluate all components, and anticipate emerging development trends.

Main Areas of Work:

• Patient Monitoring Programs
• Diagnostic Programs and Patient Selection
• Marketing Research, GR, and Market Access Programs
• Patient Support Programs
• Educational Programs for Physicians and Patients
• Pharmaceutical Market Analysis and Expertise

https://aston-health.com